MentionFox
Home › funding signals › Dewpoint Therapeutics, Inc.
Company · SEC filings

Dewpoint Therapeutics, Inc. funding history

Dewpoint Therapeutics, Inc. has 2 Form D filings on record, from 2025-09-23 to 2026-07-13. Together its new offerings report $59.12M sold.

Funding historyFounders and team

What do you want to do with Dewpoint Therapeutics, Inc.?

Based
BOSTON, MASSACHUSETTS
Industry group
Biotechnology
Filings
2
Raised (new offerings)
$59.12M

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-07-13Amendment
first sale 2025-09-09
$77.16M$82.30MSEC filing
2025-09-23New offering
first sale 2025-09-09
$59.12M$59.12MSEC filing

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from Dewpoint Therapeutics, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Cite this page

Permanent URL: https://mentionfox.com/company/dewpoint-therapeutics-inc
Last updated 2026-09-26
Primary record: SEC filing 1 · SEC filing 2
Dewpoint Therapeutics, Inc. funding history: 2 SEC filings, $59.12M raised. MentionFox, 2026-09-26. https://mentionfox.com/company/dewpoint-therapeutics-inc